Skip to main content
SpringerLink
Log in

Clinical Trials of Human Mesenchymal Stem Cells to Support Hematopoietic Stem Cell Transplantation

  • Chapter
Genetic Engineering of Mesenchymal Stem Cells

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Koç ON, Gerson S, Cooper B, et al. Rapid hematopoietic recovery after co-infusion of autologous culture-expanded human mesenchymal stem cells (hMSCs) and PBPCs in breast cancer patients receiving high dose chemotherapy. J Clin Oncol. 2000:18:307–316.

    PubMed  Google Scholar 

  2. Lennon DP, Haynesworth SE, Bruder SP, Jaiswal N, Caplan AI. Development of a serum screen for mesenchymal progenitor cells from bone marrow. In Vitro Cell Dev Biol. 1996;32:602–611.

    Article  Google Scholar 

  3. Galotto M, Berisso G, Delfino L, et al. Stromal damage as consequence of high-dose chemo/radiotherapy in bone marrow transplant recipients. Exp Hematol. 1999;27:1460–1466.

    Article  CAS  PubMed  Google Scholar 

  4. Barbot C, Rice A, Vanes I, Mahon FX, Jazwiec B, Reiffers J. Quality and functional capacity of the bone marrow microenvironment of autologous blood stem cell transplantation recipients. Nouv Rev Fr Hematol. 1994;36:325–331.

    CAS  PubMed  Google Scholar 

  5. Fried W, Kedo A, Barone J. Effects of cyclophosaphamide and of busulfan on spleen colony-forming units and on hematopoietic stroma. Cancer Res. 1977;37:1205–1209.

    CAS  PubMed  Google Scholar 

  6. McManus PM, Weiss L. Busulfan-induced chronic bone marrow failure: changes in cortical bone, marrow stromal cells, and adherent cell colonies. Blood. 1984;64:1036–1041.

    CAS  PubMed  Google Scholar 

  7. Uhlman DL, Verfaillie C, Jones RB, Luikart SD. BCNU treatment of marrow stromal monolayers reversibly alters haematopoiesis. Br J Haematol. 1991;78:3304–3309.

    Article  Google Scholar 

  8. Toksoz D, Zsebo K, Smith K, et al. Support of human hematopoiesis in long term bone marrow cultures by murine stromal cells selectively expressing the membrane bound and secreted forms of the human homologue of the steel gene product, stem cell factor. Proc Natl Acad Sci USA. 1992;89:7350–7354.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Clark B, Keating A. Biology of bone marrow stroma. Ann NY Acad Sci. 1995;770:70–88.

    Article  CAS  PubMed  Google Scholar 

  10. Haynesworth S, Baber M, Caplan A. Cytokine expression by human marrow derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1a. J Cell Physiol. 1996;166:585–592.

    Article  CAS  PubMed  Google Scholar 

  11. Majumdar MK, Thiede MA, Mosca JD, Moorman M, Gerson SL. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:186–192.

    Article  Google Scholar 

  12. Majumdar M, Thiede M, Haynesworth S, Bruder S, Gerson S. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res. 2001;9:841–848.

    Article  Google Scholar 

  13. Kadereit S, Deeds L, Haynesworth S, et al. Mesencymal stem cell as a feeder layer during short-term umbilical cord blood in vivo expansion increases early hematopoietic progenitors. Stem Cells. 2002;20:573–582.

    Article  CAS  PubMed  Google Scholar 

  14. Klyushnenkova E, Mosca J, McIntosh K. Human mesenchymal stem cells suppress allogeneic T cell responses in vitro: implications for allogeneic transplantation. Blood. 1998;92:642a.

    Google Scholar 

  15. Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002;99:3838–3843.

    Article  PubMed  Google Scholar 

  16. LeBlanc K, Tammik L, Sundberg B, Haynesworth S, Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scan J Immunol. 2003;57:11–20.

    Article  CAS  Google Scholar 

  17. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75:389–397.

    Article  CAS  PubMed  Google Scholar 

  18. Maitra B, Szekely E, Gjini K, Laughlin MJD, Haynesworth S, Koç ON. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 2003.

    Google Scholar 

  19. Farida D, Pascale P, Claire B, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003.

    Google Scholar 

  20. Krampera M, Glennie S, Dyson J, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101:3722–3729.

    Article  CAS  PubMed  Google Scholar 

  21. Anklesaria P, Kase K, Glowacki J, et al. Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci USA. 1987;1987:7681–7685.

    Article  Google Scholar 

  22. Almeida-Porada G, Flake A, Hudson A, Zanjani E. Co transplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. Exp Hematol. 1999;27:1569–1575.

    Article  CAS  PubMed  Google Scholar 

  23. Noort WA, Kruisselbrink AB, Anker PS, et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol. 2002;30:870–878.

    Article  PubMed  Google Scholar 

  24. Angelopoulou M, Novelli E, Grove J, et al. Co transplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 2003;31:413–420.

    Article  CAS  PubMed  Google Scholar 

  25. Almeida-Porada G, Porada C, Tran N, Zanjani E. Co transplantation of human stromal cell progenitors into preimmune ftal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood. 2000;95:3620–3627.

    CAS  PubMed  Google Scholar 

  26. Ishida T, Inaba M, Hisha H, et al. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor. J Immunol. 1994;152:3119–3127.

    CAS  PubMed  Google Scholar 

  27. El-Badri N, Wang BC, Good R. Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. Exp Hematol. 1998;29:110–116.

    Google Scholar 

  28. Kaufman C, Colson Y, Wren S, Watkins S, Simmons R, Ildstad S. Phenotypic characterization of a novel bone marrow-derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood. 1994;84:2436–2446.

    CAS  PubMed  Google Scholar 

  29. Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol. 2002;72:1653–1655.

    Google Scholar 

  30. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature. 1987;328:429–432.

    Article  CAS  PubMed  Google Scholar 

  31. Koç ON, Peters C, Raghavan S, et al. Bone marrow derived mesenchymal stem cells of patients with lysosomal and peroxisomal storage diseases remain host type following allogeneic bone marrow transplantation. Exp Hematol. 1999;27:1675–1681.

    Article  PubMed  Google Scholar 

  32. Horwitz EM, Prockop DJ, Fitzpatrick LA, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309–313.

    Article  CAS  PubMed  Google Scholar 

  33. Rombouts W, Ploemacher R. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia. 2003;17:160–170.

    Article  CAS  PubMed  Google Scholar 

  34. Mackenzie T, Flake A. Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis. 2001;27:601–604.

    Article  CAS  PubMed  Google Scholar 

  35. Lazarus H, Haynesworth S, Gerson S, Rosenthal N, Caplan A. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therpeutic use. Bone Marrow Transplant. 1995;16:557–564.

    CAS  PubMed  Google Scholar 

  36. Koç ON, Day J, Nieder M, Gerson S, Lazarus H, Krivit W. Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002;30:215–222.

    Article  PubMed  Google Scholar 

  37. Lazarus H, Curtin P, Devine S, McCarthy P, Holland K, Moseley AAB. Role of mesenchymal stem cells in allogeneic transplantation: early phase I clinical results. Blood. 2000;96:392a.

    Google Scholar 

  38. Horwitz E, Gordon P, Koo W, et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc Natl Acad Sci USA. 2002;99:8932–8937.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Lee S, Jang J, Cheong J, et al. Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol. 2001;118:1128–1131.

    Article  Google Scholar 

  40. MacMillan L, Ramsay N, Atkinson K, Wagner J. Ex vivo culture-expanded parental haploidentical mesenchymal stem cells promote engraftment in recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial. Blood. 2002;100:836a.

    Google Scholar 

  41. Krivit W, Day J, Koc ON, Atkinson K. Multiple mesenchymal stem cell (allogen) infusions in patients with metachromatic leukodystrophy: safety of infusions and stability of nerve conduction velocities. Blood. 2002;100:524a.

    Article  Google Scholar 

  42. Cahill R, Jones O, Mueller T, El-Badri N, Good R. Replacement of recipient stromal/mesenchymal cells after bone marrow transplant using bone fragments and cultured osteoblast like cells. Blood. 2002;100:63a.

    Google Scholar 

  43. Frassoni F, Labopin M, Bacigalupo A, et al. Expanded mesenchymal stem cells (MSC), co-infused with HLA identical hemopoietic stem cell transplants, reduce acute and chronic graft versus host disease: a matched pair analysis. Bone Marrow Transplant. 2002;29:S2.

    Google Scholar 

  44. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815–1822.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology-Oncology, Department of Medicine, Ireland Cancer Center, Cleveland, OH

    O. N. Koç

Authors
  1. O. N. Koç
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Washington University School of Medicine, St. Louis, MO, USA

    Jan A. Nolta

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer

About this chapter

Cite this chapter

Koç, O.N. (2006). Clinical Trials of Human Mesenchymal Stem Cells to Support Hematopoietic Stem Cell Transplantation. In: Nolta, J.A. (eds) Genetic Engineering of Mesenchymal Stem Cells. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3959-X_9

Download citation

Publish with us

Policies and ethics

Search

Navigation